Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

BKHAVesicor Therapeutics Holdings, Inc.

Nasdaq · CIK 0002000775
Filer category<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1130
XBRL facts94

Identity from submissions API

NameVesicor Therapeutics Holdings, Inc.
CIK0002000775
TickersBKHA, BKHAR, BKHAU
ExchangesNasdaq, Nasdaq, Nasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN000000000
LEI—
Fiscal year end1130
State of incorporation—
Phone203-520-7122
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Black Hawk Acquisition Corp (2023-12-21T00:00:00.000Z → 2026-11-16T00:00:00.000Z)
Business address
4125 BLACKHAWK PLAZA CIRCLE
SUITE 166
DANVILLE
CA
94506
CA
Mailing address
4125 BLACKHAWK PLAZA CIRCLE
SUITE 166
DANVILLE
CA
94506
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

124 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 25-NSE xslF25X02/primary_doc.xml 0001354457-26-001108 001-41984 261579915 34 3155
2026-11-20 25-NSE xslF25X02/primary_doc.xml 0001354457-26-001107 333-276857 261579839 34 3157
2026-11-20 CERT VESI_8A_Cert_2000775.pdf 0001354457-26-001101 001-41984 261578982 34 180337
2026-11-20 8-A12B 8-A12B 0001829126-26-012693 001-41984 261578010 34 19460
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001905106-26-000192 005-94481 261558387 34 7697
2026-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-125690 005-94481 261542874 34 32470
2026-11-09 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001628280-26-072383 005-94481 261537318 34 103300
2026-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001140361-26-042051 005-94481 261525133 34 12119
2026-10-23 8-K 8-K 8.01 0001829126-26-011490 001-41984 261482616 34 247667 1 1
2026-10-13 8-K 8-K 5.07 0001829126-26-011077 001-41984 261457079 34 268642 1 1
2026-10-07 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001140361-26-038899 005-94481 261446792 34 12925
2026-10-06 10-Q 10-Q 0001829126-26-010813 001-41984 261444034 34 3959839 1 1
2026-09-25 425 425 0001829126-26-010391 001-41984 261405844 34 1029478
2026-09-24 8-K 8-K 1.01,3.02,9.01 0001829126-26-010385 001-41984 261404942 34 1460391 1 1
2026-09-22 8-K 8-K 8.01 0001829126-26-010313 001-41984 261397193 34 247837 1 1
2026-09-22 424B4 424B4 0001829126-26-010292 333-292402 261395115 33 26654029
2026-09-17 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002988 333-292402 261388322 33 2658
2026-09-04 S-4/A S-4/A 0001829126-26-009732 333-292402 261360093 33 27046065
2026-08-26 8-K 8-K 1.01,2.03,3.02,9.01 0001829126-26-009347 001-41984 261320696 34 304558 1 1
2026-08-25 8-K 8-K 8.01 0001829126-26-009270 001-41984 261311913 34 245993 1 1
2026-08-03 S-4/A S-4/A 0001829126-26-008251 333-292402 261230156 33 26919811
2026-07-22 8-K 8-K 8.01 0001829126-26-007744 001-41984 261193856 34 245740 1 1
2026-07-15 10-Q 10-Q 0001829126-26-007603 001-41984 261177600 34 3546781 1 1
2026-07-06 S-4/A S-4/A 0001829126-26-007231 333-292402 261153830 33 6934088
2026-06-11 S-4/A S-4/A 0001829126-26-006338 333-292402 261081348 33 6824898
2026-05-08 8-K 8-K 1.01,2.03,3.02,9.01 0001829126-26-004870 001-41984 26958532 34 304310 1 1
2026-05-01 S-4/A S-4/A 0001829126-26-004346 333-292402 26929994 33 6139791
2026-04-28 10-K/A 10-K/A 0001829126-26-004046 001-41984 26908815 34 633479 1 1
2026-04-21 10-Q 10-Q 0001829126-26-003670 001-41984 26876348 34 3160312 1 1
2026-04-14 NT 10-Q NT 10-Q 0001829126-26-003495 001-41984 26860975 34 28642
2026-04-01 8-K 8-K 3.01 0001829126-26-003042 001-41984 26829177 34 253455 1 1
2026-03-17 8-K 8-K 5.02,7.01,9.01 0001829126-26-002413 001-41984 26763677 34 446013 1 1
2026-03-06 10-K 10-K 0001829126-26-002021 001-41984 26732186 34 4269632 1 1
2026-03-05 S-4/A S-4/A 0001829126-26-001934 333-292402 26723761 33 7504866
2026-03-02 NT 10-K NT 10-K 0001829126-26-001802 001-41984 26707501 34 29277
2026-02-19 8-K 8-K 1.01,2.03,3.02,9.01 0001829126-26-001472 001-41984 26653887 34 305141 1 1
2026-02-03 8-K 8-K 5.02 0001829126-26-000910 001-41984 26591449 34 262342 1 1
2026-01-26 S-4/A S-4/A 0001829126-26-000517 333-292402 26557920 33 6728105
2026-01-23 S-4/A S-4/A 0001829126-26-000475 333-292402 26553185 33 6784175
2025-12-29 DEL AM DEL AM 0001829126-25-010326 333-292402 251608510 33 7065
2025-12-23 S-4 S-4 0001829126-25-010259 333-292402 251599298 33 6892270 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001604488-25-000223 005-94481 251484454 34 16898
2025-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001282327-25-000018 005-94481 251477493 34 15078
2025-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001167557-25-000021 005-94481 251471439 34 10279
2025-11-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-274754 005-94481 251467736 34 115554
2025-10-21 10-Q 10-Q 0001829126-25-008277 001-41984 251405207 34 3718185 1 1
2025-10-15 NT 10-Q NT 10-Q 0001829126-25-008114 001-41984 251393231 34 28742
2025-10-10 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001140361-25-037903 005-94481 251387503 34 11782
2025-09-24 8-K 8-K 8.01 0001829126-25-007626 001-41984 251337430 34 248441 1 1
2025-09-23 DRS/A filename1.htm 0001829126-25-007578 377-08098 251331586 33 5880753
2025-08-28 8-K 8-K 8.01 0001829126-25-006840 001-41984 251274007 34 248493 1 1
2025-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-077157 005-94481 251208914 34 32341
2025-08-08 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-106010 005-94481 251199409 34 90508
2025-08-08 8-K 8-K 8.01 0001829126-25-005938 001-41984 251195838 34 248184 1 1
2025-08-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001072613-25-000507 005-94481 251193795 34 7767
2025-08-04 DRS/A filename1.htm 0001829126-25-005721 377-08098 251177791 33 5417705
2025-07-22 8-K/A 8-K/A 8.01 0001829126-25-005279 001-41984 251140837 34 257544 1 1
2025-07-14 8-K 8-K 1.01,5.03,5.07,8.01,9.01 0001829126-25-005054 001-41984 251122184 34 309303 1 1
2025-07-08 DEFA14A DEFA14A 0001829126-25-004936 001-41984 251110026 34 23070
2025-07-08 8-K 8-K 8.01,9.01 0001829126-25-004929 001-41984 251109432 34 262451 1 1
2025-07-03 8-K 8-K 8.01 0001829126-25-004895 001-41984 251106103 34 249985 1 1
2025-07-01 8-K 8-K 8.01 0001829126-25-004830 001-41984 251096322 34 249991 1 1
2025-06-27 8-K 8-K 8.01 0001829126-25-004761 001-41984 251086061 34 249984 1 1
2025-06-26 10-Q 10-Q 0001829126-25-004729 001-41984 251080971 34 2993277 1 1
2025-06-24 8-K 8-K 8.01 0001829126-25-004657 001-41984 251066156 34 248060 1 1
2025-06-23 8-K 8-K 8.01 0001829126-25-004643 001-41984 251064512 34 248049 1 1
2025-06-20 8-K 8-K 8.01,9.01 0001829126-25-004621 001-41984 251061651 34 268381 1 1
2025-06-20 DEFA14A DEFA14A 0001829126-25-004617 001-41984 251061201 34 23295
2025-06-20 8-K 8-K 8.01 0001829126-25-004598 001-41984 251059089 34 249551 1 1
2025-06-20 DEFA14A DEFA14A 0001829126-25-004588 001-41984 251058306 34 30001
2025-06-12 DRS filename1.htm 0001829126-25-004416 377-08098 251041042 33 4602550
2025-06-10 DEFR14A DEFR14A 0001829126-25-004384 001-41984 251038111 34 329044
2025-06-10 DEF 14A DEF 14A 0001829126-25-004345 001-41984 251035738 34 326506
2025-06-04 8-K 8-K 5.02 0001829126-25-004234 001-41984 251023534 34 249330 1 1
2025-05-28 PRE 14A PRE 14A 0001829126-25-004000 001-41984 25995837 34 332438
2025-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-069795 005-94481 25937121 34 139058
2025-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001085146-25-002957 005-94481 25935353 34 14299
2025-04-29 425 425 0001829126-25-003010 001-41984 25882416 34 1228669 1 1
2025-04-29 8-K 8-K 1.01,9.01 0001829126-25-003009 001-41984 25882414 34 1716051 1 1
2025-04-11 10-K/A 10-K/A 0001829126-25-002550 001-41984 25829445 34 122658
2025-04-10 10-Q 10-Q 0001829126-25-002536 001-41984 25828024 34 2688653 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001604488-25-000061 005-94481 25631947 34 16989
2025-02-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001085146-25-001197 005-94481 25618247 34 14134
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-019382 005-94481 25617522 34 728448
2025-02-07 10-K 10-K 0001829126-25-000801 001-41984 25602153 34 3446157 1 1
2024-11-15 SC 13G/A 13G/A BFAC 0001604488-24-000319 005-94481 241466031 34 80342
2024-11-14 SC 13G SC 13G 0001193125-24-259059 005-94481 241465466 34 62398
2024-11-14 SC 13G 13G BKHA 0001604488-24-000271 005-94481 241464921 34 80413
2024-11-14 SC 13G AQR CAPITAL MANAGEMENT LLC 0001085146-24-005744 005-94481 241458010 34 45162
2024-11-12 SC 13G/A SC 13G/A 0001193125-24-256006 005-94481 241448753 34 116963
2024-11-12 SC 13G formsc13g.htm 0001493152-24-044605 005-94481 241444211 34 106751
2024-09-23 10-Q 10-Q 0001829126-24-006401 001-41984 241315735 34 2601411 1 1
2024-06-28 10-Q 10-Q 0001829126-24-004489 001-41984 241086038 34 2573562 1 1
2024-06-07 SC 13G KARPUS INVESTMENT MGT / BLACK HAWK ACQUISITION CORP - SCHEDULE 13G 0001072613-24-000564 005-94481 241029195 34 77271
2024-04-26 SC 13D SC 13D 0001829126-24-002826 005-94481 24884335 34 64301
2024-04-26 4 FORM 4 0001829126-24-002825 7782
2024-04-24 8-K/A 8-K/A 5.02,8.01,9.01 0001829126-24-002731 001-41984 24866540 34 279432 1 1
2024-04-24 8-K 8-K 5.02,8.01,9.01 0001829126-24-002725 001-41984 24866150 34 272070 1 1
2024-04-19 10-Q 10-Q 0001829126-24-002656 001-41984 24858168 34 1969166 1 1
2024-04-04 8-K/A 8-K/A 8.01 0001829126-24-002200 001-41984 24821242 34 36755
2024-04-01 SC 13D SC 13D 0001829126-24-002128 005-94481 24811982 34 63944
2024-03-28 8-K 8-K 8.01,9.01 0001829126-24-001979 001-41984 24798340 34 143978
2024-03-27 SC 13G SC 13G 0001193125-24-078132 005-94481 24785659 34 114699
2024-03-26 8-K 8-K 1.01,3.02,5.03,8.01,9.01 0001829126-24-001885 001-41984 24780822 34 1882789
2024-03-25 3 FORM 3 0001829126-24-001832 2942
2024-03-25 3 FORM 3 0001829126-24-001831 5378
2024-03-25 3 FORM 3 0001829126-24-001830 2959
2024-03-25 3 FORM 3 0001829126-24-001829 2961
2024-03-25 3 FORM 3 0001829126-24-001828 5616
2024-03-22 424B4 424B4 0001829126-24-001784 333-276857 24773039 33 1441244
2024-03-21 CERT 8A_Cert_BKHA.pdf 0001354457-24-000179 001-41984 24769371 34 248144
2024-03-20 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-03-20 16:00:00 9999999995-24-000691 333-276857 24769290 33 1725
2024-03-20 S-1MEF S-1MEF 0001829126-24-001744 333-278098 24767823 33 289105
2024-03-20 8-A12B 8-A12B 0001829126-24-001743 001-41984 24767796 34 24165
2024-03-15 CORRESP filename1.htm 0001829126-24-001617 12422
2024-03-15 CORRESP filename1.htm 0001829126-24-001616 8710
2024-03-08 S-1/A S-1/A 0001829126-24-001492 333-276857 24735372 33 189623
2024-02-26 S-1/A S-1/A 0001829126-24-001093 333-276857 24673416 33 1688160
2024-02-23 CORRESP filename1.htm 0001829126-24-001094 17115
2024-02-21 UPLOAD filename1.pdf 0000000000-24-002002 377-07015 45512
2024-02-05 S-1 S-1 0001829126-24-000712 333-276857 24593758 33 5589497
2024-02-02 CORRESP filename1.htm 0001829126-24-000713 25621
2024-01-17 UPLOAD filename1.pdf 0000000000-24-000585 377-07015 47387
2023-12-21 DRS filename1.htm 0001829126-23-008166 377-07015 231506188 33 20892284

Latest XBRL company facts

One latest value per concept from companyfacts (94 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 4.15M 2026-10-06 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
dei EntityPublicFloat Entity Public Float USD 73.90M 2025-05-31 2025 FY 10-K/A 2026-04-28 0001829126-26-004046
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 126,479 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 296,410 2025-11-30 2025 FY 10-K 2026-03-06 0001829126-26-002021
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 0 2026-05-31 2026 Q2 10-Q 2026-07-15 0001829126-26-007603
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 4,538 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap AdministrativeFeesExpense Administrative Fees Expense USD 90,000 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 3,244 2025-06-01 2025-06-13 2025 Q3 10-Q 2025-10-21 0001829126-25-008277
us-gaap Assets Assets USD 26.03M 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap AssetsCurrent Assets, Current USD 41,367 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 25.99M 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap Cash Cash USD 12,052 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 0 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 12,052 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -27,469 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 11,583 2026-05-31 2026 Q2 10-Q 2026-07-15 0001829126-26-007603
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap CommonStockValue Common Stock, Value, Issued USD 203 2026-05-31 2026 Q2 10-Q 2026-07-15 0001829126-26-007603
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 1.6 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 1.51M 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap CustomerDepositsCurrent Customer Deposits, Current USD 150,000 2026-01-22 2025 FY 10-K 2026-03-06 0001829126-26-002021
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 2,634 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 1 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 150,000 2025-09-30 2025 FY 10-K 2026-03-06 0001829126-26-002021
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.06 2025-06-01 2025-06-13 2025 Q3 10-Q 2025-10-21 0001829126-25-008277
us-gaap DeferredCompensationLiabilityCurrent Deferred Compensation Liability, Current USD 2.42M 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 4.31M 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 514,493 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap Deposits Deposits USD 690,000 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 3,177 2025-09-30 2025 FY 10-K 2026-03-06 0001829126-26-002021
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 2,140 2025-08-31 2025 Q3 10-Q 2025-10-21 0001829126-25-008277
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 5.00M 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 1.02M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 211,613 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -62,875 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 3,320 2024-12-01 2025-08-31 2025 Q3 10-Q 2025-10-21 0001829126-25-008277
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 18,046 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap InterestExpense Interest Expense USD 77,056 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap InterestExpenseDebt Interest Expense, Debt USD 3,244 2025-06-01 2025-06-13 2025 Q3 10-Q 2025-10-21 0001829126-25-008277
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 666,151 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap InterestIncomeOther Interest Income, Other USD 1,797 2024-12-01 2025-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap InterestPayableCurrent Interest Payable, Current USD 100,000 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap LegalFees Legal Fees USD 514,493 2025-12-01 2026-05-31 2026 Q2 10-Q 2026-07-15 0001829126-26-007603
us-gaap Liabilities Liabilities USD 4.75M 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 26.03M 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap LiabilitiesCurrent Liabilities, Current USD 2.34M 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 1.93M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -1.50M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -459,590 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 1.30M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 1.30M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap OperatingExpenses Operating Expenses USD 30,701 2023-12-01 2024-02-29 2024 Q1 10-Q 2024-04-19 0001829126-24-002656
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -301,613 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap OtherDeferredCostsNet Other Deferred Costs, Net USD 514,493 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 10,000 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap OtherIncome Other Income USD 1.61M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap OtherSellingGeneralAndAdministrativeExpense Other Selling, General and Administrative Expense USD 211,613 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap OtherUnderwritingExpense Other Underwriting Expense USD 2.42M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap PaymentsForPurchaseOfOtherAssets1 Payments for Purchase of Other Assets USD 69.34M 2023-12-01 2024-11-30 2025 FY 10-K 2026-03-06 0001829126-26-002021
us-gaap PaymentsForUnderwritingExpense Payments for Underwriting Expense USD 690,000 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 1.10M 2023-12-01 2024-11-30 2025 FY 10-K 2026-03-06 0001829126-26-002021
us-gaap PaymentsOfOrdinaryDividends Payments of Ordinary Dividends USD 51.01M 2024-12-01 2025-11-30 2025 FY 10-K 2026-03-06 0001829126-26-002021
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 29,315 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap ProceedsFromAdvanceForAndContributionInAidOfConstructionFinancingActivity ProceedsFromAdvanceForAndContributionInAidOfConstructionFinancingActivity USD 1.01M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 915,000 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 69.34M 2024-03-01 2024-03-22 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 690,000 2023-12-01 2024-11-30 2025 FY 10-K 2026-03-06 0001829126-26-002021
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 2.35M 2023-12-01 2024-11-30 2025 FY 10-K 2026-03-06 0001829126-26-002021
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 7,400 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap ProfessionalFees Professional Fees USD 30,900 2024-12-01 2025-11-30 2025 FY 10-K 2026-03-06 0001829126-26-002021
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 1.07M 2026-06-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap RepaymentsOfOtherDebt Repayments of Other Debt USD 690,000 2023-12-01 2024-11-30 2025 FY 10-K 2026-03-06 0001829126-26-002021
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 250,000 2023-12-01 2024-11-30 2025 FY 10-K 2026-03-06 0001829126-26-002021
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -4.71M 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 1.03M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 0.013 2024-03-20 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.43M 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap SharePrice Share Price USD/shares 10 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -4.71M 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD -4.71M 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 4.78M 2025-07-01 2025-07-08 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap StockIssuedDuringPeriodSharesTreasuryStockReissued Stock Issued During Period, Shares, Treasury Stock Reissued shares 3 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments USD 172 2023-12-01 2024-11-30 2025 FY 10-K 2026-03-06 0001829126-26-002021
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 69.00M 2024-03-01 2024-05-31 2025 Q3 10-Q 2025-10-21 0001829126-25-008277
us-gaap StockIssuedDuringPeriodValueTreasuryStockReissued Stock Issued During Period, Value, Treasury Stock Reissued USD 690,000 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 25.99M 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap TemporaryEquityRedemptionPricePerShare Temporary Equity, Redemption Price Per Share USD/shares 12.24 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 450.00M 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 2.12M 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 2.12M 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2026-08-31 2026 Q3 10-Q 2026-10-06 0001829126-26-010813
us-gaap UnsecuredDebt Unsecured Debt USD 250,000 2026-05-31 2026 Q2 10-Q 2026-07-15 0001829126-26-007603

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →